Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti viral Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for Xofluza sulfur-heterocycle intermediate. Cost-effective, scalable, avoids cryogenic conditions. Ideal for API manufacturing.
Novel acidic resin catalysis for Trifluridine intermediate. Enhances purity above 98 percent, reduces emulsification, ensures scalable supply for pharmaceutical manufacturing.
Patent CN111718290B reveals a one-step synthesis for isoindoline-1-carboxylic acid derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113548999B details a Pd-catalyzed route for chiral oxindoles. Offers high enantioselectivity and scalable antiviral intermediate production.
Efficient rhodium-catalyzed asymmetric cyclopropanation for antiviral drug intermediates. High enantioselectivity and scalable process for pharmaceutical manufacturing.
Advanced convergent synthesis of Wipatasvir Intermediate A via Suzuki coupling. Reduces costs and improves yields for HCV drug manufacturing.
Patent CN103687489A reveals a safer, scalable route for 5-azaspiro[2.4]heptane-6-carboxylic acid, eliminating pyrophoric reagents for reliable HCV inhibitor supply.
Patent CN109438474A details a novel synthetic route for Pestaloxazine A intermediates, offering high purity and scalable manufacturing for antiviral drug development.
Novel pyrimidine derivative synthesis via patent CN1113237A offers high yield nucleotide precursors for antiviral drug manufacturing.
Novel patent CN120842228A offers high-yield synthesis for HIV and JAK inhibitor intermediates, ensuring cost reduction and supply chain reliability for global manufacturers.
Discover the novel one-pot synthesis of Peramivir key intermediates. Enhance supply chain reliability and reduce costs in API manufacturing with our advanced process.
Discover advanced purification methods for Tenofovir intermediates. Enhance supply chain reliability and reduce manufacturing costs with proven magnesium salt removal technology.
Patent CN108676048B reveals a novel adenosine-based route for cordycepin. Achieve high purity and cost reduction in nucleoside manufacturing with scalable catalytic transfer hydrogenation.
Novel enzyme mutant technology enables green cordycepin production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101538228A details an improved Peramivir synthesis with higher yield and safety. Discover cost reduction in API manufacturing and supply chain reliability.
Patent CN103468757A details a green enzymatic reduction for Atazanavir intermediates, offering high purity and safer manufacturing for pharmaceutical supply chains.
Patent CN112939798A reveals a green amidation route for amantadine using PIL-1, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Novel synthesis route for anti-CVB3 matrine derivatives offering higher yield and purity above 98 percent. Scalable industrial production achieved without column chromatography ensures reliable supply chain continuity for global pharmaceutical manufacturers.
Patent CN114149475B reveals a novel two-step Azvudine synthesis avoiding phosphorus oxychloride, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1805920A details a scalable route for HCV protease inhibitor intermediates using TEMPO oxidation and mild hydration, ensuring high purity and supply chain reliability.